IngeneerUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, FranceLille, Nord-Pas-de-Calais, France
PB1376 - Plasminogen activator inhibitor- 1 (PAI-1) as an early marker of COVID-19 severity in patients with high fibrosis-4 index
Tuesday, June 25, 202413:45 – 14:45 ICT